Valuation: Genex Pharmaceutical, Inc.

Market Cap 268K 235K 219K 201K 377K 25.92M 384K 2.62M 1.02M 12.64M 1M 983K 43.87M P/E 2006
3.75x
P/E 2007 15.1x
Enterprise Value 413K 363K 337K 310K 581K 39.95M 592K 4.03M 1.57M 19.49M 1.55M 1.52M 67.6M EV / Sales 2006
0.95x
EV / Sales 2007 1.6x
Free-Float
99.62%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 72 -
Director of Finance/CFO 72 2010-02-23
Director TitleAgeSince
Chairman 72 2010-02-23
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-39.83% - - 1.78K
+3.15%-3.69%-20.44%+7.91% 122B
+0.13%-2.82%-4.52%-6.91% 12.52B
-0.48%-2.10%+58.47%+103.22% 8.93B
-3.47%+7.68%-43.01%-67.18% 4.67B
-0.59%-8.62%+0.88%+38.75% 2.63B
-0.51%-3.00%-10.36%-22.28% 1.63B
+1.24%-5.85%-22.89%-31.52% 1.63B
-1.85%-7.16%-5.92%-60.04% 1.5B
Average -1.12%-1.54%-5.98%-4.76% 19.47B
Weighted average by Cap. -0.13%-3.28%-14.74%+9.07%

Financials

2006 2007
Net sales 2.44M 2.14M 1.99M 1.83M 3.44M 236M 3.5M 23.82M 9.29M 115M 9.15M 8.96M 400M 3.24M 2.85M 2.64M 2.43M 4.56M 313M 4.64M 31.63M 12.34M 153M 12.15M 11.89M 530M
Net income 619K 544K 506K 465K 872K 59.94M 888K 6.05M 2.36M 29.24M 2.32M 2.27M 101M 343K 301K 280K 257K 483K 33.17M 491K 3.35M 1.31M 16.18M 1.29M 1.26M 56.13M
Net Debt -0.19 -0.17 -0.16 -0.14 -0.27 -18.61 -0.28 -1.88 -0.73 -9.08 -0.72 -0.71 -31.5 0.14 0.13 0.12 0.11 0.2 14.03 0.21 1.42 0.55 6.84 0.54 0.53 23.74
Logo Genex Pharmaceutical, Inc.
Genex Pharmaceutical Inc is a company primarily engaged in the provision of bone grafting products and services. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The Company distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.
Employees
-